SG/PUT/NOVO-NORDISK B/700/0.1/21.03.25 Share Price

Warrant

DE000SW7ZJH9

Market Closed - Boerse Frankfurt Warrants 11:51:46 03/07/2024 pm IST
0.31 EUR +14.81% Intraday chart for SG/PUT/NOVO-NORDISK B/700/0.1/21.03.25
Current month+3.85%
1 month-35.71%
Date Price Change
03/24/03 0.31 +14.81%
02/24/02 0.27 +12.50%
01/24/01 0.24 -7.69%
28/24/28 0.26 0.00%
27/24/27 0.26 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 11:51 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ZJH
ISINDE000SW7ZJH9
Date issued 20/03/2024
Strike 700 kr
Maturity 21/03/2025 (261 Days)
Parity 10 : 1
Emission price 0.68
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.76
Lowest since issue 0.22
Delta0x
Omega 0.000000
Premium0x
Gearing40.5x
Moneyness 0.7235
Difference Strike -267.5 kr
Difference Strike %-38.21%
Spread 0.02
Spread %6.06%
Intrinsic value 0.000000
Present value 0.3200

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus